vs
Orthofix Medical Inc.（OFIX）与POWER SOLUTIONS INTERNATIONAL, INC.（PSIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是POWER SOLUTIONS INTERNATIONAL, INC.的1.2倍（$219.9M vs $191.2M），POWER SOLUTIONS INTERNATIONAL, INC.净利率更高（8.4% vs -1.0%，领先9.4%），POWER SOLUTIONS INTERNATIONAL, INC.同比增速更快（32.5% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-7.6M），过去两年POWER SOLUTIONS INTERNATIONAL, INC.的营收复合增速更高（41.7% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
阿达尼能源解决方案有限公司（前身为阿达尼输电有限公司）是一家电力输配企业，总部位于艾哈迈达巴德。截至2025年4月，公司累计输电网络总长26696回路公里，是印度规模最大的民营输电企业之一。
OFIX vs PSIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$191.2M
营收增速更快
PSIX
高出30.5%
2.0%
净利率更高
PSIX
高出9.4%
-1.0%
自由现金流更多
OFIX
多$24.4M
$-7.6M
两年增速更快
PSIX
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $191.2M |
| 净利润 | $-2.2M | $16.1M |
| 毛利率 | 71.1% | 21.9% |
| 营业利润率 | 0.2% | 12.7% |
| 净利率 | -1.0% | 8.4% |
| 营收同比 | 2.0% | 32.5% |
| 净利润同比 | 92.4% | -31.0% |
| 每股收益（稀释后） | $-0.05 | $0.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPSIX
| Q4 25 | $219.9M | $191.2M | ||
| Q3 25 | $205.6M | $203.8M | ||
| Q2 25 | $203.1M | $191.9M | ||
| Q1 25 | $193.6M | $135.4M | ||
| Q4 24 | $215.7M | $144.3M | ||
| Q3 24 | $196.6M | $125.8M | ||
| Q2 24 | $198.6M | $110.6M | ||
| Q1 24 | $188.6M | $95.2M |
净利润OFIXPSIX
| Q4 25 | $-2.2M | $16.1M | ||
| Q3 25 | $-22.8M | $27.6M | ||
| Q2 25 | $-14.1M | $51.2M | ||
| Q1 25 | $-53.1M | $19.1M | ||
| Q4 24 | $-29.1M | $23.3M | ||
| Q3 24 | $-27.4M | $17.3M | ||
| Q2 24 | $-33.4M | $21.5M | ||
| Q1 24 | $-36.0M | $7.1M |
毛利率OFIXPSIX
| Q4 25 | 71.1% | 21.9% | ||
| Q3 25 | 72.2% | 23.9% | ||
| Q2 25 | 68.7% | 28.2% | ||
| Q1 25 | 62.8% | 29.7% | ||
| Q4 24 | 69.0% | 29.9% | ||
| Q3 24 | 68.7% | 28.9% | ||
| Q2 24 | 67.8% | 31.8% | ||
| Q1 24 | 67.5% | 27.0% |
营业利润率OFIXPSIX
| Q4 25 | 0.2% | 12.7% | ||
| Q3 25 | -8.3% | 13.9% | ||
| Q2 25 | -7.9% | 16.9% | ||
| Q1 25 | -25.2% | 18.2% | ||
| Q4 24 | -5.3% | 17.5% | ||
| Q3 24 | -9.6% | 16.3% | ||
| Q2 24 | -12.5% | 22.9% | ||
| Q1 24 | -15.6% | 11.2% |
净利率OFIXPSIX
| Q4 25 | -1.0% | 8.4% | ||
| Q3 25 | -11.1% | 13.5% | ||
| Q2 25 | -6.9% | 26.7% | ||
| Q1 25 | -27.4% | 14.1% | ||
| Q4 24 | -13.5% | 16.1% | ||
| Q3 24 | -13.9% | 13.8% | ||
| Q2 24 | -16.8% | 19.5% | ||
| Q1 24 | -19.1% | 7.5% |
每股收益（稀释后）OFIXPSIX
| Q4 25 | $-0.05 | $0.69 | ||
| Q3 25 | $-0.57 | $1.20 | ||
| Q2 25 | $-0.36 | $2.22 | ||
| Q1 25 | $-1.35 | $0.83 | ||
| Q4 24 | $-0.76 | $1.01 | ||
| Q3 24 | $-0.71 | $0.75 | ||
| Q2 24 | $-0.88 | $0.94 | ||
| Q1 24 | $-0.95 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $41.3M |
| 总债务越低越好 | — | $96.6M |
| 股东权益账面价值 | $450.0M | $178.6M |
| 总资产 | $850.6M | $424.7M |
| 负债/权益比越低杠杆越低 | — | 0.54× |
8季度趋势，按日历期对齐
现金及短期投资OFIXPSIX
| Q4 25 | $82.0M | $41.3M | ||
| Q3 25 | $62.9M | $49.0M | ||
| Q2 25 | $65.6M | $49.5M | ||
| Q1 25 | $58.0M | $50.0M | ||
| Q4 24 | $83.2M | $55.3M | ||
| Q3 24 | $30.1M | $40.5M | ||
| Q2 24 | $26.4M | $28.8M | ||
| Q1 24 | $27.0M | $33.1M |
总债务OFIXPSIX
| Q4 25 | — | $96.6M | ||
| Q3 25 | $157.2M | $96.7M | ||
| Q2 25 | $157.0M | $1.8M | ||
| Q1 25 | $156.9M | $1.0M | ||
| Q4 24 | $157.0M | $184.0K | ||
| Q3 24 | $118.5M | $238.0K | ||
| Q2 24 | $118.0M | $292.0K | ||
| Q1 24 | $118.2M | $345.0K |
股东权益OFIXPSIX
| Q4 25 | $450.0M | $178.6M | ||
| Q3 25 | $442.5M | $162.5M | ||
| Q2 25 | $458.3M | $135.7M | ||
| Q1 25 | $458.3M | $84.3M | ||
| Q4 24 | $503.1M | $65.3M | ||
| Q3 24 | $525.9M | $42.1M | ||
| Q2 24 | $546.0M | $24.8M | ||
| Q1 24 | $570.3M | $3.2M |
总资产OFIXPSIX
| Q4 25 | $850.6M | $424.7M | ||
| Q3 25 | $832.6M | $458.9M | ||
| Q2 25 | $837.2M | $437.7M | ||
| Q1 25 | $823.1M | $372.7M | ||
| Q4 24 | $893.3M | $328.2M | ||
| Q3 24 | $867.9M | $339.1M | ||
| Q2 24 | $882.0M | $307.6M | ||
| Q1 24 | $906.0M | $286.8M |
负债/权益比OFIXPSIX
| Q4 25 | — | 0.54× | ||
| Q3 25 | 0.36× | 0.60× | ||
| Q2 25 | 0.34× | 0.01× | ||
| Q1 25 | 0.34× | 0.01× | ||
| Q4 24 | 0.31× | 0.00× | ||
| Q3 24 | 0.23× | 0.01× | ||
| Q2 24 | 0.22× | 0.01× | ||
| Q1 24 | 0.21× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-4.6M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-7.6M |
| 自由现金流率自由现金流/营收 | 7.6% | -4.0% |
| 资本支出强度资本支出/营收 | 4.9% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.29× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $14.1M |
8季度趋势，按日历期对齐
经营现金流OFIXPSIX
| Q4 25 | $27.7M | $-4.6M | ||
| Q3 25 | $12.4M | $3.3M | ||
| Q2 25 | $11.6M | $16.7M | ||
| Q1 25 | $-18.4M | $8.8M | ||
| Q4 24 | $23.7M | $32.7M | ||
| Q3 24 | $11.7M | $12.6M | ||
| Q2 24 | $9.0M | $1.5M | ||
| Q1 24 | $-18.6M | $15.6M |
自由现金流OFIXPSIX
| Q4 25 | $16.8M | $-7.6M | ||
| Q3 25 | $2.5M | $1.7M | ||
| Q2 25 | $4.5M | $14.6M | ||
| Q1 25 | $-25.1M | $5.4M | ||
| Q4 24 | $15.2M | $30.0M | ||
| Q3 24 | $6.3M | $12.1M | ||
| Q2 24 | $-360.0K | $822.0K | ||
| Q1 24 | $-29.1M | $14.8M |
自由现金流率OFIXPSIX
| Q4 25 | 7.6% | -4.0% | ||
| Q3 25 | 1.2% | 0.8% | ||
| Q2 25 | 2.2% | 7.6% | ||
| Q1 25 | -13.0% | 4.0% | ||
| Q4 24 | 7.0% | 20.8% | ||
| Q3 24 | 3.2% | 9.7% | ||
| Q2 24 | -0.2% | 0.7% | ||
| Q1 24 | -15.4% | 15.6% |
资本支出强度OFIXPSIX
| Q4 25 | 4.9% | 1.6% | ||
| Q3 25 | 4.8% | 0.8% | ||
| Q2 25 | 3.5% | 1.1% | ||
| Q1 25 | 3.5% | 2.5% | ||
| Q4 24 | 4.0% | 1.8% | ||
| Q3 24 | 2.7% | 0.3% | ||
| Q2 24 | 4.7% | 0.6% | ||
| Q1 24 | 5.6% | 0.9% |
现金转化率OFIXPSIX
| Q4 25 | — | -0.29× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 2.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PSIX
| Energy End Market | $153.4M | 80% |
| Industrial End Market | $33.3M | 17% |
| Transportation End Market | $4.6M | 2% |
